Showing results (1091-1100 of 1,194) with videos related to
Sort By:
Pageof 120
Pharmaceutical Statistics|February 15, 2021
Response-adaptive trial designs with accelerated Thompson samplingJixian WangPharmaceutical Statistics|November 4, 2016
Proposed best practice for projects that involve modelling and simulationMichael O'Kelly, Vladimir Anisimov, Chris Campbell, et al.Pharmaceutical Statistics|February 27, 2019
Estimation of drug effect in radiographic progression for rheumatoid arthritis and psoriatic arthritisBin Dong, Jiandong LuPharmaceutical Statistics|February 27, 2019
Milestone prediction for time-to-event endpoint monitoring in clinical trialsFang-Shu Ou, Martin Heller, Qian ShiPharmaceutical Statistics|November 19, 2016
A novel sample size formula for the weighted log-rank test under the proportional hazards cure modelXiaoping Xiong, Jianrong WuPharmaceutical Statistics|April 2, 2019
Bayesian sequential integration within a preclinical pharmacokinetic and pharmacodynamic modeling framework: Lessons learnedFabiola La Gamba, Tom Jacobs, Helena Geys, et al.Pharmaceutical Statistics|August 20, 2019
Oncology phase II proof-of-concept studies with multiple targets: Randomized controlled trial or single arm?Thomas Jemielita, Archie Tse, Cong ChenPharmaceutical Statistics|October 30, 2018
Controlling type 1 error rate for sequential, bioequivalence studies with crossover designsHans E Rasmussen, Rick Ma, Jessie J WangPharmaceutical Statistics|November 9, 2018
Treatment policy estimands for recurrent event data using data collected after cessation of randomised treatmentJames H Roger, Daniel J Bratton, Bhabita Mayer, et al.Pharmaceutical Statistics|November 16, 2018
Bayesian sample size determination for phase IIA clinical trials using historical data and semi-parametric prior's elicitationPaola Berchialla, Sarah Zohar, Ileana BaldiPageof 120